000 04146nam a2200469 i 4500
003 ESmaUEC
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
040 _aES-MaUEC
_bspa
_cES-MaUEC
336 _aTexto
_btxt
_2rdacontent
710 2 _aSpringerLink (Online service)
_9106996
999 _c109334
_d109334
_x1
001 109334
005 20230102113411.0
008 190325s2019 si | o |||| 0|eng d
020 _a9789811361869
024 7 _a10.1007/978-981-13-6186-9
_2doi
050 4 _aQP551
_b2019 EB
245 0 0 _aProgranulin and Central Nervous System Disorders
_cedited by Hideaki Hara, Masato Hosokawa, Shinsuke Nakamura, Takayoshi Shimohata, Masugi Nishihara.
264 1 _aSingapore
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (VII, 183 páginas)
_b37 ilustraciones, 13 ilustraciones a color
337 _aelectrónico
_bc
338 _arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aChapter 1. Molecular and Functional Properties of Progranulin -- Chapter 2. Progranulin as a biomarker for neurodegenerative diseases -- Chapter 3. PGRN and FTLD -- Chapter 4. PGRN and neurodegenerative diseases other than FTLD -- Chapter 5. Progranulin Regulations of Lysosomal Homeostasis and its Involvement in Neurodegenerative Diseases -- Chapter 6. Molecular and Functional Properties of Progranulin -- Chapter 7. PGRN and neuroinflammation -- Chapter 8. Neural Stem/Progenitor Cells and Progranulin -- Chapter 9. Generation and phenotyping of progranulin-deficient mice -- Chapter 10. Pleiotropic protective effects of progranulin in the treatment of ischemic stroke -- Chapter 11. New therapeutic approaches against ocular diseases.
520 3 _aThis book presents the latest knowledge on the roles of progranulin (PGRN) in normal physiology and pathology and explores the emerging significance of PGRN as a therapeutic target and biomarker in various CNS disorders, including frontotemporal lobe degeneration and other neurodegenerative diseases. Following initial recognition of the importance of PGRN in sexual differentiation of the developing brain and adult neurogenesis, it was subsequently discovered that PGRN acts as a chaperone of lysosomal enzymes and plays a crucial role in maintaining cellular protein homeostasis. It has also been found that sex steroids modulate the expression of PGRN and its trophic effects in the developing CNS and that PGRN directly or indirectly influences neural stem and progenitor cells. Against this background, deeper understanding of the molecular and functional properties of PGRN would provide fresh impetus for the development of mechanism-based therapeutic approaches for multiple disorders. Medications targeting the recovery of lysosomal function appear to hold particular promise in patients with neurodegenerative diseases resulting from PGRN insufficiency. In examining multiple aspects of this fascinating field, the book will be of high value for researchers and graduate students.
988 _aPrimersemestre_2019_BiomedLife
650 7 _2embne
_aProteínas
_9139861
650 7 _2embne
_9670257
_aGlucoproteínas
650 7 _2embne
_9161615
_aNeurogenética
700 1 _aHara, Hideaki.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHosokawa, Masato.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aNakamura, Shinsuke.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aNishihara, Masugi.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aShimohata, Takayoshi.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9789811361852
776 0 8 _iPrinted edition:
_z9789811361876
776 0 8 _iPrinted edition:
_z9789811361883
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-6186-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _aSI
_cm
_dz
_feng
_ggw
_h0
_b08/2019
_ek
_zSI